IRCT2013083114530N1CompletedPhase 1
Finasteride effect as a treatment for chronic and recurrent central serous Chorioretinopathy(CSC)
Shahid Sadoughi University of Medical Science0 sites30 target enrollmentStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 30
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- no limit to no limit (—)
- Sex
- All
Inclusion Criteria
- •Eligibility criteria:patients with chronic CSCR, which was defined in this study as 1) the presence of subretinal fluid, as determined by spectraldomain OCT;2)the subretinal fluid must have been present for at least 3 months or there was a recurrence of subretinal fluid in ipsilateral eye within the past 3 months.
- •exclusion criteria:corticosteroid use,CNV or other ocular disease that disturb the study outcome,pregnant and nursery women
Exclusion Criteria
- Not provided
Investigators
Similar Trials
Completed
Phase 4
Chronotherapy with finasteride in patients with androgenetic alopeciaandrogenetic alopeciaJPRN-UMIN000009623Jichi Medical University66
Completed
Phase 3
Effect of finasterid on COVID-19 treatmentCorona virus pneumonia.COVID-19,virus not identifiedU07.2IRCT20200505047318N1Qazvin University of Medical Sciences80
Completed
Phase 1
The impact of topical finasteride on male-pattern baldnessAndrogenic alopecia.Androgenic alopeciaIRCT201202048917N1Tabriz University of Medical Sciences58
Recruiting
Phase 3
The effect of finasteride in the prevention of bladder tumor recurrenceIRCT20200608047702N1Tabriz University of Medical Sciences124
Completed
Phase 4
Management of male pattern baldnessCTRI/2017/10/010156JNMC Sawangi Meghe Wardha25